Gennex Laboratories Limited (BOM:531739)
India · Delayed Price · Currency is INR 8.92
-0.16 (-1.76%)
At close: Jul 27, 2026
Gennex Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 2,167 | 1,732 | 2,741 | 3,594 | 1,004 | 953 | |
Market Cap Growth | -26.71% | -36.80% | -23.73% | 257.85% | 5.42% | 92.58% |
Enterprise Value | 2,540 | 2,224 | 2,569 | 3,775 | 1,030 | 1,022 |
Last Close Price | 8.92 | 7.13 | 12.05 | 15.80 | 5.61 | 7.18 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 11.71 | 8.26 | 15.12 | 27.28 | 20.41 | 24.28 |
PS Ratio | 1.25 | 1.00 | 1.99 | 4.14 | 1.53 | 1.56 |
PB Ratio | 0.93 | 0.74 | 1.41 | 2.04 | 1.16 | 2.17 |
P/TBV Ratio | 0.99 | 0.79 | 1.49 | 2.15 | 1.35 | 2.17 |
P/FCF Ratio | - | - | - | - | - | 9.24 |
P/OCF Ratio | - | - | - | - | 4.24 | 8.00 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.47 | 1.29 | 1.86 | 4.35 | 1.57 | 1.67 |
EV/EBITDA Ratio | 11.32 | 9.91 | 15.08 | 21.72 | 20.72 | 18.67 |
EV/EBIT Ratio | 12.83 | 11.24 | 17.08 | 25.14 | 25.42 | 21.81 |
EV/FCF Ratio | - | - | - | - | - | 9.91 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.34 | 0.34 | 0.14 | 0.11 | 0.20 | 0.23 |
Debt / EBITDA Ratio | 3.54 | 3.54 | 1.59 | 1.09 | 3.49 | 1.85 |
Debt / FCF Ratio | - | - | - | - | - | 0.98 |
Net Debt / Equity Ratio | 0.12 | 0.12 | -0.14 | -0.23 | 0.04 | 0.06 |
Net Debt / EBITDA Ratio | 1.20 | 1.20 | -1.61 | -2.37 | 0.63 | 0.48 |
Net Debt / FCF Ratio | -0.36 | -0.36 | 1.39 | 0.89 | -0.19 | 0.26 |
Asset Turnover | 0.57 | 0.57 | 0.57 | 0.48 | 0.66 | 0.97 |
Inventory Turnover | 2.86 | 2.86 | 3.20 | 2.42 | 3.44 | 6.02 |
Quick Ratio | 1.33 | 1.33 | 1.60 | 1.97 | 0.81 | 0.81 |
Current Ratio | 3.66 | 3.66 | 4.07 | 4.01 | 1.65 | 1.95 |
Return on Equity (ROE) | 9.82% | 9.82% | 9.77% | 10.02% | 7.55% | 9.39% |
Return on Assets (ROA) | 4.09% | 4.09% | 3.87% | 5.18% | 2.53% | 4.62% |
Return on Invested Capital (ROIC) | 6.67% | 8.16% | 8.43% | 10.67% | 4.60% | 7.74% |
Return on Capital Employed (ROCE) | 7.20% | 7.20% | 7.10% | 7.90% | 3.90% | 10.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 9.68% | 12.11% | 6.61% | 3.67% | 4.90% | 4.12% |
FCF Yield | -34.88% | -43.64% | -7.20% | -12.99% | -16.04% | 10.83% |
Buyback Yield / Dilution | -18.95% | -18.95% | -6.81% | -40.48% | -21.94% | - |